CIK 0000885725
- Large accelerated filer
BOSTON SCIENTIFIC CORP
Sign in to watch- Ticker
- BSX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042695240
- Phone
- +1 508-683-4000
- Business address
- 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, 01752-1234
- Open-market buys, last 90 days
- $100,408
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$100,408. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-13 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Option exercise | +79,264 | $7.39 | $586K | 296,135 |
| 2022-12-13 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Sale | −79,264 | $47.78 | $3.8M | 216,871 |
| 2022-12-13 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Option exercise · Stock Option (Right to Buy) | −79,264 | 0 | ||
| 2022-12-12 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Sale | −11,080 | $46.75 | $518K | 88,479 |
| 2022-12-09 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Option exercise | +29,599 | $13.08 | $387K | 140,591 |
| 2022-12-09 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Sale | −41,032 | $46.15 | $1.9M | 99,559 |
| 2022-12-09 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Option exercise · Stock Option (Right to Buy) | −29,599 | 0 | ||
| 2022-12-03 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Option exercise | +649 | 111,288 | ||
| 2022-12-03 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Shares withheld for taxes | −296 | $46.60 | $14K | 110,992 |
| 2022-12-03 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Option exercise · Deferred Stock Units | −649 | 649 | ||
| 2022-11-29 | Connors Nelda J Director | Sale | −18,196 | $44.47 | $809K | 27,246 |
| 2022-11-18 | Thepaut Eric Francis Yves EVP & Pres, Eur, Mid-East, Afr | Sale | −14,952 | $42.72 | $639K | 57,533.99 |
| 2022-11-15 | Carruthers Wendy EVP, Human Resources | Sale | −1,678 | $42.60 | $71K | 94,913 |
| 2022-11-07 | Mahoney Michael F Chairman, President & CEO | Option exercise | +82,567 | $7.39 | $610K | 1,850,232 |
| 2022-11-07 | Mahoney Michael F Chairman, President & CEO | Option exercise | +43,260 | $13.08 | $566K | 1,893,492 |
| 2022-11-07 | Mahoney Michael F Chairman, President & CEO | Sale | −125,827 | $41.97 | $5.3M | 1,767,665 |
| 2022-11-07 | Mahoney Michael F Chairman, President & CEO | Option exercise · Stock Option (Right to Buy) | −43,260 | 173,041 | ||
| 2022-11-07 | Mahoney Michael F Chairman, President & CEO | Option exercise · Stock Option (Right to Buy) | −82,567 | 0 | ||
| 2022-11-01 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Gift | −230 | 110,639 | ||
| 2022-10-17 | Carruthers Wendy EVP, Human Resources | Sale | −13,322 | $40.52 | $540K | 96,591 |
Page 64 of 69 · 1,373 trades